Avid Bioservices Inc (CDMO)

[cjgaddy]

2nd SITC’17(Nov8-12) Title: Joint MSKCC(Wolchok Lab)+PPHM

Nov8-12 2017: “(SITC) Society for Immunotherapy of Cancer 32nd Annual Meeting”, Natl-Harbor MD
”The premier destination for scientific exchange, education, and networking in the Cancer Immunotherapy Field”
SITC = The Society for Immunotherapy of Cancer http://www.sitcancer.org
SITC 2017 Meeting: http://www.sitcancer.org/2017/home
Abstracts: http://www.sitcancer.org/2017/abstracts All abstracts submitted to the SITC 32nd Annual Meeting will be published in the Journal for ImmunoTherapy of Cancer (JITC), the official journal of SITC. Regular abstracts will be published on Tuesday, Nov. 7 and LBA's will be published on Dec. 7.
= = = = =So far:
1. “Results of Epigenetic-Based Quantitative PCR Assisted Immune Cell Counting Analysis in Bavituximab SUNRISE Trial Subgroup”
https://www.sitcancer.org/2017/abstracts/titles/biomarkers-immune-monitoring
Nikoletta L. Kallinteris 1, Thomas O. Kleen 2, Min Tang 1, Shen Yin 1, Tobi Guennel 3, Jennifer Lai 1, Victor Nowakowski 2, Steven Olek 2, Steve King 1, Joseph S. Shan 1
1 Peregrine Pharmaceuticals
2 Epiontis GmbH, Berlin, Germany
3 Precision Medicine, Frederick MD

2. “Phosphatidylserine Targeting Antibody In Combination With Tumor Radiation & Immune Checkpoint Blockade Promotes Anti-Tumor Activity in Mouse B16 Melanoma”
https://www.sitcancer.org/2017/abstracts/titles/combination-therapy
Sadna Budhu 1, Rachel Giese 1, Olivier De Henau 1, Roberta Zappasodi 1, Luis Felipe Campesato 1, Aditi Gupta 1, Christopher Barker 1, Bruce Freimark 2, Jedd D. Wolchok 1, Taha Merghoub 1
1 Memorial Sloan Kettering Cancer Center, NYC
2 Peregrine Pharmaceuticals, Inc.
...NOTE: This same joint PPHM+MSKCC poster was presented 11-11-16 at SITC’16 (http://tinyurl.com/js3fca4 ) and 4-2-17 at AACR’17 (http://tinyurl.com/lxlltd6 ).

= = = = = = = = = =
Peregrine began working w/Mem-Sloan-Kettering(Jedd Wolchok Lab) in Jul'15 (2 known studies a/o 4-2017: #1/Bavi+PD1+Rad, #2/Bavi+”ACT”) to investigate “Novel PS-Targeting Immunotherapy Combos”. See: http://tinyurl.com/lxlltd6